Therapeutic agent for disease based on inhibitory effect of macrophage migration inhibitory factor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9918963
APP PUB NO 20160228404A1
SERIAL NO

15132892

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for treating the relapsing-remitting or secondary progressive multiple sclerosis at the time of relapse, by administering a benzopyran derivative of the following formula or a salt thereof,

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TOYAMA CHEMICAL CO LTDSHINJUKU-KU TOKYO 160-0023

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Morimoto, Kimiko Toyama, JP 5 4
Tanaka, Keiichi Toyama, JP 226 4320

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00